For example, a novel combination of a PTEN plasmid (PL‐NANO) along with a BRD4-targeting PROTAC (AL‐NANO) resulted in synergistic tumor inhibition and apoptosis in 2D and 3D melanoma models [155]. Here, PTEN is linked to melanoma.